| Guadalupe Medical Group, Llc | |
| 1855 E Guadalupe Rd, Ste 112, Tempe, Arizona 85283 | |
| (480) 839-8552 |
| Name | Guadalupe Medical Group, Llc |
|---|---|
| Organization Name | Guadalupe Medical Group Llc |
| Location | 1855 E Guadalupe Rd, Ste 112, Tempe, Arizona 85283 |
| Type | Supplier |
| Phone | (480) 839-8552 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Difficult to treat and aggressive "triple-negative" breast cancer is chemoresistant even before chemotherapy begins, a new study by researchers from Karolinska Institutet and the University of Texas MD Anderson Cancer Center reports. The findings, which are published in the journal Cell, may lead to better and more personalized treatments for breast cancer.
Eli Lilly and Company today announced its detailed results for the Phase 3, double-blind, placebo-controlled EXPEDITION studies in patients with mild-to-moderate Alzheimer's disease.
WuXi PharmaTech today announced that it has a contract manufacturing agreement with TaiMed Biologics Inc. for the manufacture of ibalizumab (TMB-355) in support of Phase 2 and Phase 3 clinical trials globally.
Most people would agree that arsenic, lead, mercury, benzene and carbon monoxide pose dangers to humans. Not many, though, realize that the average person is exposed to about 10,000 different chemicals per day.
› Verified 2 days ago
News Archive
Difficult to treat and aggressive "triple-negative" breast cancer is chemoresistant even before chemotherapy begins, a new study by researchers from Karolinska Institutet and the University of Texas MD Anderson Cancer Center reports. The findings, which are published in the journal Cell, may lead to better and more personalized treatments for breast cancer.
Eli Lilly and Company today announced its detailed results for the Phase 3, double-blind, placebo-controlled EXPEDITION studies in patients with mild-to-moderate Alzheimer's disease.
WuXi PharmaTech today announced that it has a contract manufacturing agreement with TaiMed Biologics Inc. for the manufacture of ibalizumab (TMB-355) in support of Phase 2 and Phase 3 clinical trials globally.
Most people would agree that arsenic, lead, mercury, benzene and carbon monoxide pose dangers to humans. Not many, though, realize that the average person is exposed to about 10,000 different chemicals per day.
› Verified 2 days ago
Accredo Health Group Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2040 W Rio Salado Pkwy, Tempe, Arizona 85281 Phone: (800) 232-1199 | |
Arizona Ocuar Prosthetics, Llc Type: Medicare Supplier Location: 3025 S Kenneth Pl, Tempe, Arizona 85282 Phone: (480) 264-3041 | |
Breg, Inc. Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1860 W. University Drive, Tempe, Arizona 85281 Phone: (480) 257-7110 | |
Option Care Type: Medicare Supplier Location: 7850 S Hardy Dr, Tempe, Arizona 85284 Phone: (480) 897-2927 | |
Desert Eye Type: Medicare Supplier Location: 3200 S Rural Rd, Tempe, Arizona 85282 Phone: (480) 966-0522 |